2014
DOI: 10.1016/j.bmc.2014.02.012
|View full text |Cite
|
Sign up to set email alerts
|

A new potential approach to block HIV-1 replication via protein–protein interaction and strand-transfer inhibition

Abstract: Therapeutic treatment of AIDS is recently characterized by a crescent effort towards the identification of multiple ligands able to target different steps of HIV-1 life cycle. Taking into consideration our previously obtained SAR information and combining some important chemical structural features we report herein the synthesis of novel benzyl-indole derivatives as anti-HIV agents. Through this work we identified new dual target small molecules able to inhibit both IN-LEDGF/p75 interaction and the IN strand-t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(5 citation statements)
references
References 38 publications
0
5
0
Order By: Relevance
“…As a continuation of our previous studies on anti‐HIV agents and in particular on HIV‐IN enzyme inhibitors,,, herein we report the results of a research on PPIIs.…”
Section: Resultsmentioning
confidence: 87%
“…As a continuation of our previous studies on anti‐HIV agents and in particular on HIV‐IN enzyme inhibitors,,, herein we report the results of a research on PPIIs.…”
Section: Resultsmentioning
confidence: 87%
“…Experimental approaches of relevance, although still in early stages, include: (i) inhibition of viral DNA integration into the host genome is accomplished by preventing PIC transport into the nucleus. This is put into practice by integrase-mediated nuclear import inhibitors, which bind to the host cell's nuclear import protein [142]; (ii) IN-mediated chromatin remodeling inhibitors (ICRIs). In this case, inhibition of v-DNA integration into the host genome by preventing the opening of the chromatin structure is targeted by the host cell's chromatin remodeling factors [143].…”
Section: New Strategies Against Retrovirus Resistancementioning
confidence: 99%
“…Based on the previously obtained SAR information and benzylindole derivatives (97,98) as anti-HIV agents, Stefania Ferro and coworkers reported their research on the identification of new dual target small molecules able to target different steps of HIV-1 life cycle (Fig. 25), and obtained two series of novel anti-HIV agents (105,106), some of which are dual inhibitors of the integration process acting both in the IN strand-transfer step and by disrupting the proteineprotein interaction between IN and its cofactor LEDGF/ p75, and compound 107 is the most active one [92].…”
Section: Indole Derivatives As Integrase (In) Inhibitorsmentioning
confidence: 99%